Cross Border Compliance with Attorney Benjamin L. England

First FDA-Regulated Import? The Mistakes That Get Shipments Stopped

Episode Summary: In this episode of FDA Imports: Cross-Border Compliance, host Sean O'Connor is joined by Attorney Benjamin England, founder of FDAImports.com and a former FDA regulatory counsel. They delve into the complexities of first-time FDA-regulated imports, highlighting common mistakes that lead to shipment delays, detentions, or refusals. Benjamin emphasizes the importance of understanding FDA requirements from the outset, including proper documentation and compliance checks before goods leave the foreign supplier. They discuss assumptions that new importers make about FDA requirements, the role of timing in import processes, and the impact of labeling and registration details on shipments. The episode provides valuable insights for businesses entering the US market, offering practical strategies to avoid common pitfalls and ensure smooth import operations. Key Timestamps: 00:00 – Introduction 00:26 – Common Mistakes in First-Time Imports 01:12 – Importance of Early Transaction Compliance 02:39 – Assumptions About FDA Requirements 03:47 – Challenges with Proprietary Information 05:03 – Role of Customs Brokers 06:01 – FDA's Authority at the Border 07:07 – Labeling and Product Compliance Issues 08:15 – Differing FDA Expectations by Product Type 10:18 – Timing and Its Impact on Imports 12:33 – Perishable Goods and Timing Challenges 14:17 – Case Study: Dietary Supplements 17:08 – Cosmetic Products with Drug Claims 19:18 – Impact of Initial Non-Compliance on Future Imports About the Show: FDA Imports: Cross-Border Compliance is a podcast dedicated to helping businesses navigate the intricate world of FDA regulations and international trade. Hosted by industry experts, the show provides insightful discussions on compliance strategies, regulatory updates, and best practices for importing FDA-regulated products. Whether you're a seasoned importer or new to the field, this podcast offers valuable knowledge to ensure your business meets regulatory standards and avoids common pitfalls. With a focus on clarity and practical advice, FDA Imports is your go-to resource for staying informed and compliant in the ever-evolving landscape of cross-border trade.

TrumpRx.gov Explained: Why FDA and Customs Are Cracking Down on Drug Imports

Episode Summary: In this episode of *FDA Imports: Cross-Border Compliance* Benjamin England delves into the significance of TrumpRX.gov in the context of drug pricing policy and pharmaceutical importation. Exploring the complexities of pharmaceutical pricing disparities between the US and Europe, Ben sheds light on the regulatory changes initiated by the Trump administration to facilitate the importation of pharmaceuticals, offering a potential solution to high drug costs for American consumers. Key Timestamps: 00:00 – Introduction 02:30 – TrumpRX.gov: A Game-Changer in Pharmaceutical Pricing 06:45 – The Implications of Temporary Programs on Industry Players 10:15 – Enforcement Approaches to Gray Market Rx Drugs 14:50 – Mitigating Risks in Pharmaceutical Importation 18:25 – The Complexities of Regulatory Scrutiny and Sourcing Patterns About the Show: *FDA Imports: Cross-Border Compliance* provides expert insights into cross-border compliance issues related to FDA regulations and international trade. Led by Attorney Benjamin England, the show navigates the intricate landscape of FDA oversight, regulatory compliance, and importation challenges faced by businesses worldwide.

FDA’s ‘No Artificial Colors’ Shift: When Enforcement Changes but the Law Doesn’t

Episode Summary: In this episode of FDA Imports: Cross Border Compliance with Attorney Benjamin England sheds light on the FDA's recent enforcement discretion around color additives, impacting labeling regulations and creating confusion for importers. He clarifies the distinction between natural and synthetic colors, discusses the FDA's changing approach to artificial colors claims, and outlines the compliance challenges importers may face in light of this guidance. Key Timestamps: 00:00 – Introduction 02:15 – Differentiating between natural and synthetic colors 04:30 – FDA's enforcement discretion on artificial colors claims 07:45 – Compliance implications for importers 11:20 – Potential risks and considerations for companies 15:00 – Navigating FDA's evolving enforcement expectations About the Show: *FDA Imports: Cross Border Compliance with Attorney Benjamin England* is the go-to podcast for insights into cross-border compliance issues, hosted by industry expert Benjamin England. Join as the show unravel the complexities of FDA regulations and provide valuable guidance for businesses dealing with import compliance challenges.

Customs Brokers vs. FDA Compliance: Where Importers Get Bad Information

Episode Summary: In this episode, Benjamin England delves into the complexities of FDA compliance for importers and customs brokers. He highlights the common misunderstandings that lead to compliance breakdowns and emphasizes the crucial role importers play in ensuring regulatory adherence. From the responsibilities of customs brokers to the challenges faced at the border, this episode offers valuable insights for companies navigating FDA regulations in international trade. Key Timestamps: 00:00 – Introduction to FDA Compliance & Broker Responsibilities 01:20 – Importer vs. Customs Broker Roles Explained 03:00 – Where the Assumption Breaks Down 04:30 – Broker Limitations & Experience Gaps 06:00 – Common Communication Failures Before Shipment 07:30 – What Happens at the Border When Compliance Fails 09:00 – Missing Data, Approvals & Entry Errors 10:30 – Who Bears the Risk: Importer vs Manufacturer 12:00 – Consequences: Refusal, Export, or Destruction 13:30 – Broker Liability & Contract Limitations 14:50 – Managing Risk & Verifying Broker Accuracy 16:00 – Structuring Responsibilities & Contracts About the Show: *FDA Imports* is a podcast series hosted by Benjamin England, focusing on the intricate landscape of FDA compliance in cross-border trade. With expert insights and practical guidance, the show equips businesses with the knowledge needed to navigate regulatory challenges effectively.

FDA Corrective Action Plans: Why Most CAPAs Fail and What Actually Works

Episode Summary: Benjamin England delves into the intricate world of FDA corrective action plans, shedding light on why many plans fail to meet FDA standards despite companies' efforts. From understanding the root cause to the importance of documentation, Ben provides invaluable insights into creating effective action plans that satisfy FDA requirements. Key Timestamps: 00:00 – Introduction to FDA Imports & Corrective Action Plans 01:20 – What is a CAPA & When FDA Requires It 03:10 – Import Alerts, Root Cause Analysis & CAPA Process 05:00 – Why CAPAs Fail: Root Cause Challenges 06:40 – Investigations & Common Mistakes in CAPAs 08:20 – Importance of Documentation & Evidence 10:00 – Implementation Records & Proving Compliance 11:40 – Systemic Fix vs Temporary Fix 13:10 – Supplier Risks & Real-World Examples 14:40 – Timing of CAPA & Impact on Import Status 16:00 – Ongoing Imports & Strategic Timing Considerations 17:00 – FSVP, Verification & FDA Expectations About the Show: *FDA Imports* is your go-to resource for navigating the complex world of FDA compliance in international trade. Join us as we unravel the nuances of FDA regulations, offering expert guidance to ensure your company stays in line with FDA requirements.